Mr. Riccardo Calandrelli serves as a Principal Scientist II at Athos Therapeutics, Inc., where he develops and applies computational methodologies for large-scale autoimmune multi-omics data analysis and integration, and collaborates closely with software designers and engineers to optimize the Athos computational platform. Prior to joining Athos, Riccardo served as a Bioinformatics Programmer at the Institute […] The post Riccardo Calandrelli appeared first on Athos Therapeutics .